Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming Co-Epidemics.
Tsegaye Melaku KebedeLegese ChelkebaZeleke MekonnenKabaye KumelaPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
Significant gaps were observed in achieving the recommended glycemic target and involvement of patients on self-care care behavior in the study area. The co-occurrence of tuberculosis, human immunodeficiency virus, and diabetes is triple trouble needing special attention in their management. It is high time to leverage the clinical care of the looming co-epidemics through chronic comprehensive care clinic.
Keyphrases
- human immunodeficiency virus
- glycemic control
- type diabetes
- healthcare
- hepatitis c virus
- palliative care
- antiretroviral therapy
- quality improvement
- cardiovascular disease
- blood glucose
- mycobacterium tuberculosis
- primary care
- newly diagnosed
- emergency department
- hiv positive
- skeletal muscle
- adipose tissue
- pulmonary tuberculosis